News & Updates
Showing Respirology articles
Showing
Ivonescimab trumps tislelizumab for squamous NSCLC in HARMONi-6
In the phase III HARMONi-6 trial, ivonescimab plus chemotherapy significantly improved progression-free survival (PFS) compared with tislelizumab plus chemo as first-line treatment for individuals with advanced squamous non-small cell lung cancer (NSCLC).
Ivonescimab trumps tislelizumab for squamous NSCLC in HARMONi-6
06 Jan 2026
No safe level of smoking, study says
Smoking even in low intensity still results in increased cardiovascular risk, reveals a study, noting that the primary public health message for current smokers should be early cessation instead of smoking reduction.
No safe level of smoking, study says
14 Dec 2025
HCPs, patients willing to trade off OCS benefits to avoid side effects
Both patients and healthcare professionals prefer treatment for asthma attacks that avoids the side effects of oral corticosteroids (OCS), and both are willing to trade off benefits, according to a study.
HCPs, patients willing to trade off OCS benefits to avoid side effects
12 Dec 2025
SARS-CoV-2 reinfection ups paediatric long COVID risk
Findings from the retrospective RECOVER-EHR* study show an increased risk of post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID, in children and adolescents after a SARS-CoV-2 reinfection.